alexa Left Main Percutaneous Coronary Intervention For Acute Coronary Syndrome
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

World Heart Congress
May 22- 24, 2017 Osaka, Japan

Shivaji Silwal, Bharat Rawat, Shekhar Rajbhandari, Jay Prakash Jaiswal and Rajiv Shrestha
Norvic International Hospital, Nepal
Posters & Accepted Abstracts: J Clin Exp Cardiolog
DOI: 10.4172/2155-9880-C1-069
Abstract
Introduction: Unprotected Left Main coronary artery disease (ULMCA) is seen in 1-2% of acute coronary syndrome (ACS) patients. It is a clinically catastrophic event, often leading to abrupt and severe circulatory failure, lethal arrhythmias and sudden cardiac death. Background & Aims: Though coronary artery bypass graft surgery has traditionally been the preferred approach to revascularization, recent guidelines support the use of percutaneous coronary intervention (PCI) in such cases. Methods: A retrospective analysis of data was done for five patients who underwent coronary angioplasty from 2008 till now of ULMCA. Results: 4 out of the 5 patients presented with non-ST elevation acute coronary syndrome (NSTE-ACS) and one patient with ST elevation acute coronary syndrome (STE-ACS). All the patients were shifted to cathlab within an hour of arrival. One patient was treated with thrombo-suction but he died after repeated ventricular tachycardia and ventricular fibrillation. The remaining four were successfully treated with ballooning, followed by left main to left anterior descending (LAD) artery stenting. All of them were given long-term dual antiplatelet drugs. One died after seven years due to an abdominal malignancy. Another patient died due to possible sudden cardiac death and the remaining two are in follow up for more than a year, and are asymptomatic. Conclusions: ULMCA PCI for ACS should be done rapidly. Simple strategy of stenting from left main to LAD is preferred wherever feasible. These patients should be closely followed with proper emphasis on dual anti platelet drugs.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords